Finance Watch: Verona Accesses Up To $650m As Ensifentrine Approval Deadline Nears

Firm’s Second Big Financing In 2024

 
• By Mandy Jackson
  
Finance Watch Public Company
• Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business